Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities:
Net loss	$ (14,337,256)	$ (7,761,200)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	2,605,052	2,179,827
Debt discount amortization	0	258,682
Stock and warrants issued for debt	0	873,519
Loss on asset dispositions	0	50,255
Minority interest in earnings of subsidiary	(9,089)	7,361
Stock issued for stock based compensation	873,270	177,000
Warrants issued for services performed	0	318,750
Warrants issued for interest	47,275	0
Stock issued for interest	400,515	0
Stock issued for services	0	746,346
Loss from discountinued operations	7,979,891	1,865,895
Increases/decreases in operating assets and liabilities
Accounts receivable	(615,499)	(257,614)
Prepaid expenses and other assets	173,276	(199,237)
Accounts payable and accrued expenses	2,298,127	930,750
Derivative liability	108,180	513,471
Net cash (used) in/provided by operating activities	(467,173)	(296,195)
Cash flows from investing activities:
Purchase of property and equipment	(1,613,368)	(68,311)
Purchase of discontinued operations	0	(100,000)
Net cash used in investing activities	(1,613,368)	(168,311)
Cash flows from financing activities:
Repayments of notes payable	(1,373,016)	(1,478,123)
Proceeds of long term debt	3,075,868	906,240
Net proceeds/(repayments) from line of credit	(154,917)	140,109
Bank overdraft	479,100	47,337
Proceeds from the sale of common stock / exercise of warrants	82,500	855,000
Net cash (used) in/provided by financing activities	2,109,535	470,563
Net change in cash	28,994	6,057
Cash, beginning of period	54,158	48,101
Cash, end of period	83,152	54,158
Supplemental disclosure of cash flow information:
Income taxes paid	0	0
Interest paid	0	510,623
Common stock issued for acquisition of subsidiaries
Common stock issued in purchase	1,542,237	200,000
Notes payable issued in purchase	4,000,000	250,000
Less: assets received in purchase, net of cash	0	595,879
Plus: liabilities assumed during purchase	0	145,879
Minority interest	0	0
Net cash received at purchase	0	0
Capitalized Lease entered into by Subsidiary	1,653,513	0
Common stock issued for stock based compensation	873,270	177,000
Common stock and warrants issued for deferred finance costs, extension of loans and with notes payable	400,515	133,500
Common stock issued for conversion of debentures	$ 47,275	$ 1,566,567